Peginterferon beta-1a Subcutaneous and Ranibizumab
Determining the interaction of Peginterferon beta-1a Subcutaneous and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: peginterferon beta-1a
Brand name: Plegridy, Plegridy Pen, Plegridy Pen Starter Pack, Plegridy Starter Pack
Synonyms: Peginterferon beta-1a, Peginterferon Beta-1a
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Peginterferon beta-1a Subcutaneous-Ranibizumab Intraocular
- Peginterferon beta-1a Subcutaneous-Ranibizumab ophthalmic
- Peginterferon beta-1a Subcutaneous-Ranitidine
- Peginterferon beta-1a Subcutaneous-Ranitidine Capsule
- Peginterferon beta-1a Subcutaneous-Ranitidine Hydrochloride
- Peginterferon beta-1a Subcutaneous-Ranitidine Injection
- Ranibizumab-PegIntron
- Ranibizumab-Pegloticase
- Ranibizumab-Pegloticase Intravenous
- Ranibizumab-Pegvaliase
- Ranibizumab-Pegvaliase-pqpz
- Ranibizumab-Pegvaliase-pqpz Subcutaneous